- Home
- GALT vs NKSH Comparison
GALT vs NKSH Comparison
Compare GALT & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GALT | NKSH |
|---|---|---|
| Founded | 2000 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | 237.1M |
| IPO Year | 2008 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GALT | NKSH |
|---|---|---|
| Price | $2.36 | $37.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 337.9K | 65.9K |
| Earning Date | 05-14-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.04% |
| EPS Growth | 36.84 | ★ 100.81 |
| EPS | N/A | ★ 2.49 |
| Revenue | N/A | ★ $8,176,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.95 |
| Revenue Growth | N/A | ★ 9.39 |
| 52 Week Low | $1.22 | $24.74 |
| 52 Week High | $7.13 | $40.00 |
Technical Indicators
Market Signals| Indicator | GALT | NKSH |
|---|---|---|
| Relative Strength Index (RSI) | 43.69 | 55.22 |
| Support Level | $2.13 | $37.32 |
| Resistance Level | $3.32 | $38.07 |
| Average True Range (ATR) | 0.20 | 0.80 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 30.47 | 68.02 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural loans, commercial real estate, construction loans for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary. The company earns its revenue from interest and fees on loans, non-interest income, and investments.